CYTOKINETICS, INCORPORATED Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-02-26: Form 10-K; Exhibit 10.34; Description Description of Director Compensation.
- 2026-02-26: Form 10-K; Exhibit 10.23; Description Amendment No. 1 to the Collaboration and License Agreement, dated November 18, 2024, by and between the Company and Bayer Consumer Care AG.
- 2026-02-26: Form 10-K; Exhibit 10.11; Description Amended and Restated 2004 Equity Incentive Plan.
- 2025-02-27: Form 10-K; Exhibit 10.33; Description Description of Director Compensation.
| Filed | Form | Exhibit | Description |
|---|
| 2026-02-26 | 10-K | 10.34 | Description of Director Compensation |
|---|
| 2026-02-26 | 10-K | 10.23 | Amendment No. 1 to the Collaboration and License Agreement, dated November 18, 2024, by and between the Company and Bayer Consumer Care AG |
|---|
| 2026-02-26 | 10-K | 10.11 | Amended and Restated 2004 Equity Incentive Plan |
|---|